Stockreport

Bausch wins US appeal to block Alvogen generic of diarrhea drug [Reuters]

Bausch + Lomb Corporation  (BLCO) 
PDF , opens new tab that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029. A Delaware federal co [Read more]